Titre : Nodules pulmonaires multiples

Nodules pulmonaires multiples : Questions médicales fréquentes

Termes MeSH sélectionnés :

Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nodules pulmonaires multiples : Questions médicales les plus fréquentes", "headline": "Nodules pulmonaires multiples : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nodules pulmonaires multiples : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2025-03-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nodules pulmonaires multiples" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs du poumon", "url": "https://questionsmedicales.fr/mesh/D008175", "about": { "@type": "MedicalCondition", "name": "Tumeurs du poumon", "code": { "@type": "MedicalCode", "code": "D008175", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.520" } } }, "about": { "@type": "MedicalCondition", "name": "Nodules pulmonaires multiples", "alternateName": "Multiple Pulmonary Nodules", "code": { "@type": "MedicalCode", "code": "D055613", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Y L Gao", "url": "https://questionsmedicales.fr/author/Y%20L%20Gao", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China." } }, { "@type": "Person", "name": "R E Feng", "url": "https://questionsmedicales.fr/author/R%20E%20Feng", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China." } }, { "@type": "Person", "name": "Kazuhiko Morikawa", "url": "https://questionsmedicales.fr/author/Kazuhiko%20Morikawa", "affiliation": { "@type": "Organization", "name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan." } }, { "@type": "Person", "name": "Shigeki Misumi", "url": "https://questionsmedicales.fr/author/Shigeki%20Misumi", "affiliation": { "@type": "Organization", "name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan." } }, { "@type": "Person", "name": "Taiki Fukuda", "url": "https://questionsmedicales.fr/author/Taiki%20Fukuda", "affiliation": { "@type": "Organization", "name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Coordination of CcpA and CodY Regulators in Staphylococcus aureus USA300 Strains.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36321827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/msystems.00480-22" } }, { "@type": "ScholarlyArticle", "name": "Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36047838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/pde.15017" } }, { "@type": "ScholarlyArticle", "name": "Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.", "datePublished": "2022-07-22", "url": "https://questionsmedicales.fr/article/35973315", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.diagmicrobio.2022.115772" } }, { "@type": "ScholarlyArticle", "name": "Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.", "datePublished": "2023-07-26", "url": "https://questionsmedicales.fr/article/37494330", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0287973" } }, { "@type": "ScholarlyArticle", "name": "Fucoxanthin Potentiates the Bactericidal Activity of Cefotaxime Against Staphylococcus aureus.", "datePublished": "2023-06-26", "url": "https://questionsmedicales.fr/article/37365295", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00284-023-03381-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012142" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du poumon", "item": "https://questionsmedicales.fr/mesh/D008175" }, { "@type": "ListItem", "position": 5, "name": "Nodules pulmonaires multiples", "item": "https://questionsmedicales.fr/mesh/D055613" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nodules pulmonaires multiples - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nodules pulmonaires multiples", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nodules pulmonaires multiples", "description": "Comment sont détectés les nodules pulmonaires multiples ?\nQuels examens complémentaires sont nécessaires ?\nQuels critères évaluent la malignité des nodules ?\nLes antécédents médicaux influencent-ils le diagnostic ?\nQuelle est l'importance du suivi des nodules ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=Staphylococcus+aureus&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nodules pulmonaires multiples", "description": "Quels sont les symptômes des nodules pulmonaires multiples ?\nLes nodules peuvent-ils causer des infections ?\nLes symptômes varient-ils selon l'étiologie ?\nPeut-on avoir des symptômes sans nodules visibles ?\nLes symptômes sont-ils toujours graves ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=Staphylococcus+aureus&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nodules pulmonaires multiples", "description": "Comment prévenir les nodules pulmonaires ?\nLes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle le risque ?\nLe contrôle des maladies respiratoires aide-t-il ?\nLes vaccinations sont-elles utiles ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=Staphylococcus+aureus&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nodules pulmonaires multiples", "description": "Quel traitement pour les nodules bénins ?\nComment traite-t-on les nodules malins ?\nLes traitements varient-ils selon la taille des nodules ?\nY a-t-il des traitements expérimentaux ?\nLe suivi post-traitement est-il important ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=Staphylococcus+aureus&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nodules pulmonaires multiples", "description": "Quelles complications peuvent survenir ?\nLes nodules peuvent-ils causer des problèmes respiratoires ?\nY a-t-il un risque de métastases ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=Staphylococcus+aureus&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nodules pulmonaires multiples", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents de cancer augmentent-ils le risque ?\nL'exposition professionnelle joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=Staphylococcus+aureus&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment sont détectés les nodules pulmonaires multiples ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent détectés par radiographie ou tomodensitométrie (TDM)." } }, { "@type": "Question", "name": "Quels examens complémentaires sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie ou une imagerie par résonance magnétique (IRM) peut être nécessaire." } }, { "@type": "Question", "name": "Quels critères évaluent la malignité des nodules ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La taille, la forme, la calcification et l'évolution des nodules sont évaluées." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer ou de tabagisme augmentent le risque de malignité." } }, { "@type": "Question", "name": "Quelle est l'importance du suivi des nodules ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le suivi permet de surveiller l'évolution des nodules et d'identifier des changements." } }, { "@type": "Question", "name": "Quels sont les symptômes des nodules pulmonaires multiples ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Souvent asymptomatiques, ils peuvent causer toux, douleur thoracique ou dyspnée." } }, { "@type": "Question", "name": "Les nodules peuvent-ils causer des infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections pulmonaires peuvent survenir en raison de l'inflammation." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'étiologie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer selon qu'ils sont bénins ou malins." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans nodules visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent exister sans nodules détectables par imagerie." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours graves ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, beaucoup de cas sont bénins et asymptomatiques, nécessitant juste un suivi." } }, { "@type": "Question", "name": "Comment prévenir les nodules pulmonaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et les expositions environnementales nocives aide à prévenir." } }, { "@type": "Question", "name": "Les dépistages réguliers sont-ils recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dépistages réguliers sont conseillés pour les personnes à risque élevé." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut réduire le risque de cancer pulmonaire." } }, { "@type": "Question", "name": "Le contrôle des maladies respiratoires aide-t-il ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, contrôler des maladies comme l'asthme peut réduire le risque de complications." } }, { "@type": "Question", "name": "Les vaccinations sont-elles utiles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations contre la grippe et le pneumocoque peuvent prévenir des infections." } }, { "@type": "Question", "name": "Quel traitement pour les nodules bénins ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les nodules bénins nécessitent souvent aucun traitement, juste une surveillance." } }, { "@type": "Question", "name": "Comment traite-t-on les nodules malins ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les nodules malins peuvent nécessiter chirurgie, chimiothérapie ou radiothérapie." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la taille des nodules ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la taille et la croissance des nodules influencent le choix du traitement." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux comme l'immunothérapie sont en cours d'évaluation." } }, { "@type": "Question", "name": "Le suivi post-traitement est-il important ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le suivi est crucial pour détecter toute récidive ou complication." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'infection, l'hémorragie ou la progression vers le cancer." } }, { "@type": "Question", "name": "Les nodules peuvent-ils causer des problèmes respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nodules volumineux peuvent entraîner des difficultés respiratoires." } }, { "@type": "Question", "name": "Y a-t-il un risque de métastases ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nodules malins peuvent se propager à d'autres organes par métastases." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares, surtout si les nodules sont surveillés correctement." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion dépend de la nature de la complication et peut nécessiter un traitement spécifique." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des agents cancérigènes et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de nodules pulmonaires augmente avec l'âge." } }, { "@type": "Question", "name": "Les antécédents de cancer augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de cancer augmente le risque de développer des nodules." } }, { "@type": "Question", "name": "L'exposition professionnelle joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des expositions à l'amiante ou à d'autres substances toxiques augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (4232 au total)

Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.

The objective of this study was to examine the occurrence, determinants, and outcome of S. aureus bloodstream infections (BSI) diagnosed based on single versus multiple positive initial cultures.... All adults with first episodes of mono-microbial S. aureus BSI in Queensland during 2000-2019 were included.... 10,855 (67%) and 5,421 (33%) were diagnosed based on one and multiple positive initial cultures, respectively. Patients with multiple positive initial cultures were significantly younger, more likely ... Among patients with S. aureus BSI, those diagnosed by single positive initial blood cultures have different clinical features and a higher risk for death....

Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.

Fluoroquinolone (FQ) is a potent antibiotic class. However, resistance to this class emerges quickly which hinders its application. In this study, mechanisms leading to the emergence of multidrug-resi... S. aureus ATCC 29213 was serially exposed to ciprofloxacin (CIP), ofloxacin (OFL), or levofloxacin (LEV) at sub-minimum inhibitory concentrations (sub-MICs) for 12 days to obtain S. aureus -1 strains ... A strong and irreversible increase of MICs was observed in all applied FQs (32 to 128 times) in all S. aureus-1 and remained 16 to 32 times in all S. aureus-2. WGS indicated 10 noticeable mutations oc... The emergence of MDR S. aureus was associated with the mutations in the FQ-target sequences and the overexpression of efflux pump systems and their regulators....

Prognostic significance of early platelet dynamics in Staphylococcus aureus bacteremia.

Platelets are recognized as key immune effectors, but they are targets of bacterial virulence factors. In the present study, we aimed to examine the relationship between early platelet dynamics and th... Electronic medical records of adult patients hospitalized for SAB between July 2012 and November 2020 were retrospectively reviewed for relevant demographic, laboratory, and clinical data. The outcome... Among the 811 patients evaluated, 29% experienced thrombocytopenia on Day 1. Platelet count nadir occurred on Days 2-3 following SAB onset, and Day 4 was a determining point of platelet count trajecto... Early platelet dynamics during SAB have prognostic significance and represent an early window for potential platelet-directed therapeutic interventions to improve outcome....

Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection.

The aim was to compare the incidence of Staphylococcus aureus bacteremia in COVID-19 and non-COVID-19 adult patients during the pandemic period versus the previous two years. Also, we described the ch... Retrospective study in our tertiary-care centre reviewing S. aureus bacteremia episodes in COVID-19 and non-COVID-19 patients through clinical records and the Microbiology Department database.... In 2018 and 2019, the incidence of S. aureus bacteremia episodes was 1.95 and 1.63 per 1000 admissions respectively. In the pandemic period, global incidence was 1.96 episodes per 1000 non-COVID-19 ad... We showed a significantly high rates of S. aureus bacteremia incidence in COVID-19 patients and higher methicillin resistance and 15-day mortality rates than in non-COVID-19 patients....

Treatment Failure in Vertebral Osteomyelitis: Is it All About Staphylococcus aureus ?

Retrospective cohort study.... The aim was to compare the influence of 2 common vertebral osteomyelitis (VO) causing pathogens on treatment failure within the first year of diagnosis.... VO is mainly caused by Staphylococcus aureus (SA), while enterococci and streptococci (ENST) are also responsible for a significant proportion of VO, particularly in elderly patients. Data on VO cause... We conducted a retrospective monocentric study including VO patients from 2008 to 2020. Primary outcome was treatment failure defined as death or relapse within 1 year (T1). We compared patients diagn... Data of 130 VO patients (SA=95; ENST=35) were available at T1. Treatment failure occurred in 37% of SA patients and 23% of ENST patients. On multivariate analysis SA [odds ratio (OR): 3.12; 95% confid... In our cohort every third patient with VO caused by SA or ENST dies within 1 year. Our findings indicate that patients with VO caused by SA, concomitant IE and/or a high Charlson comorbidity index sco...